Yigal Nochomovitz
Stock Analyst at Citigroup
(3.34)
# 1,007
Out of 4,975 analysts
308
Total ratings
44.9%
Success rate
3.69%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yigal Nochomovitz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AVBP ArriVent BioPharma | Maintains: Buy | $40 → $33 | $20.13 | +63.93% | 3 | Aug 12, 2025 | |
| ARCT Arcturus Therapeutics Holdings | Maintains: Buy | $47 → $49 | $17.85 | +174.51% | 6 | Aug 12, 2025 | |
| OLMA Olema Pharmaceuticals | Maintains: Buy | $20 → $21 | $8.31 | +152.71% | 2 | Aug 12, 2025 | |
| ZLAB Zai Lab | Maintains: Buy | $66 → $69 | $30.76 | +124.32% | 9 | Aug 11, 2025 | |
| BMEA Biomea Fusion | Maintains: Buy | $9 → $7 | $1.92 | +264.58% | 10 | Aug 11, 2025 | |
| ZYME Zymeworks | Maintains: Buy | $19 → $22 | $15.05 | +46.18% | 17 | Aug 11, 2025 | |
| LXRX Lexicon Pharmaceuticals | Maintains: Buy | $1.2 → $1.9 | $1.09 | +74.31% | 12 | Aug 7, 2025 | |
| SNDX Syndax Pharmaceuticals | Maintains: Buy | $46 → $51 | $17.04 | +199.30% | 9 | Aug 5, 2025 | |
| KRYS Krystal Biotech | Maintains: Neutral | $176 → $166 | $150.27 | +10.47% | 6 | Aug 5, 2025 | |
| APLS Apellis Pharmaceuticals | Maintains: Buy | $46 → $52 | $28.13 | +84.86% | 17 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $49 → $52 | $41.98 | +23.87% | 4 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $7 | $18.71 | -62.59% | 1 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $9 | $2.25 | +300.00% | 2 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $14 | $5.50 | +154.55% | 1 | Jun 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $9.5 | $7.83 | +21.33% | 10 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $10 | $6.52 | +53.37% | 15 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $23 → $35 | $25.98 | +34.72% | 5 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $49 → $55 | $41.34 | +33.04% | 11 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $5.00 | +400.00% | 1 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $89 → $82 | $54.86 | +49.47% | 21 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $33 | $14.01 | +135.55% | 1 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $89 → $97 | $67.47 | +43.77% | 16 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $8 | $0.47 | +1,588.12% | 10 | Nov 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $6 | $1.87 | +220.86% | 5 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $27 | $20.51 | +31.64% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $8 → $2 | $1.55 | +29.03% | 4 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $58 | $27.16 | +113.55% | 3 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $14 | $2.00 | +600.00% | 14 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.5 → $1.2 | $1.23 | -2.44% | 9 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $38 | $12.19 | +211.73% | 7 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $14 | $10.88 | +28.68% | 6 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.8 → $2 | $2.45 | -18.37% | 3 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $8 | $5.56 | +43.88% | 10 | Oct 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.5 → $1 | $4.40 | -77.27% | 4 | Sep 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $50 → $35 | $12.74 | +174.73% | 12 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $130 → $133 | $31.79 | +318.37% | 15 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $16 | $2.65 | +503.77% | 3 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $10 | $1.01 | +890.10% | 6 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $44 | $3.41 | +1,190.32% | 2 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $12 | $2.05 | +485.39% | 1 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $5.03 | - | 14 | Sep 28, 2021 |
ArriVent BioPharma
Aug 12, 2025
Maintains: Buy
Price Target: $40 → $33
Current: $20.13
Upside: +63.93%
Arcturus Therapeutics Holdings
Aug 12, 2025
Maintains: Buy
Price Target: $47 → $49
Current: $17.85
Upside: +174.51%
Olema Pharmaceuticals
Aug 12, 2025
Maintains: Buy
Price Target: $20 → $21
Current: $8.31
Upside: +152.71%
Zai Lab
Aug 11, 2025
Maintains: Buy
Price Target: $66 → $69
Current: $30.76
Upside: +124.32%
Biomea Fusion
Aug 11, 2025
Maintains: Buy
Price Target: $9 → $7
Current: $1.92
Upside: +264.58%
Zymeworks
Aug 11, 2025
Maintains: Buy
Price Target: $19 → $22
Current: $15.05
Upside: +46.18%
Lexicon Pharmaceuticals
Aug 7, 2025
Maintains: Buy
Price Target: $1.2 → $1.9
Current: $1.09
Upside: +74.31%
Syndax Pharmaceuticals
Aug 5, 2025
Maintains: Buy
Price Target: $46 → $51
Current: $17.04
Upside: +199.30%
Krystal Biotech
Aug 5, 2025
Maintains: Neutral
Price Target: $176 → $166
Current: $150.27
Upside: +10.47%
Apellis Pharmaceuticals
Aug 1, 2025
Maintains: Buy
Price Target: $46 → $52
Current: $28.13
Upside: +84.86%
Aug 1, 2025
Maintains: Buy
Price Target: $49 → $52
Current: $41.98
Upside: +23.87%
Jul 24, 2025
Initiates: Sell
Price Target: $7
Current: $18.71
Upside: -62.59%
Jul 9, 2025
Maintains: Buy
Price Target: $6 → $9
Current: $2.25
Upside: +300.00%
Jun 26, 2025
Initiates: Buy
Price Target: $14
Current: $5.50
Upside: +154.55%
May 5, 2025
Maintains: Neutral
Price Target: $10 → $9.5
Current: $7.83
Upside: +21.33%
May 2, 2025
Maintains: Buy
Price Target: $11 → $10
Current: $6.52
Upside: +53.37%
Mar 26, 2025
Upgrades: Buy
Price Target: $23 → $35
Current: $25.98
Upside: +34.72%
Mar 6, 2025
Maintains: Buy
Price Target: $49 → $55
Current: $41.34
Upside: +33.04%
Feb 20, 2025
Initiates: Buy
Price Target: $25
Current: $5.00
Upside: +400.00%
Feb 18, 2025
Maintains: Buy
Price Target: $89 → $82
Current: $54.86
Upside: +49.47%
Jan 7, 2025
Initiates: Buy
Price Target: $33
Current: $14.01
Upside: +135.55%
Dec 9, 2024
Maintains: Buy
Price Target: $89 → $97
Current: $67.47
Upside: +43.77%
Nov 29, 2024
Maintains: Buy
Price Target: $13 → $8
Current: $0.47
Upside: +1,588.12%
Nov 26, 2024
Maintains: Buy
Price Target: $30 → $6
Current: $1.87
Upside: +220.86%
Oct 8, 2024
Initiates: Buy
Price Target: $27
Current: $20.51
Upside: +31.64%
Oct 2, 2024
Downgrades: Neutral
Price Target: $8 → $2
Current: $1.55
Upside: +29.03%
Aug 27, 2024
Maintains: Buy
Price Target: $60 → $58
Current: $27.16
Upside: +113.55%
Aug 15, 2024
Maintains: Buy
Price Target: $16 → $14
Current: $2.00
Upside: +600.00%
Jun 18, 2024
Maintains: Neutral
Price Target: $3.5 → $1.2
Current: $1.23
Upside: -2.44%
Jun 3, 2024
Maintains: Buy
Price Target: $36 → $38
Current: $12.19
Upside: +211.73%
May 7, 2024
Maintains: Buy
Price Target: $15 → $14
Current: $10.88
Upside: +28.68%
Apr 18, 2024
Maintains: Neutral
Price Target: $1.8 → $2
Current: $2.45
Upside: -18.37%
Oct 17, 2023
Maintains: Buy
Price Target: $25 → $8
Current: $5.56
Upside: +43.88%
Sep 18, 2023
Maintains: Neutral
Price Target: $1.5 → $1
Current: $4.40
Upside: -77.27%
Aug 21, 2023
Maintains: Sell
Price Target: $50 → $35
Current: $12.74
Upside: +174.73%
Jun 7, 2023
Maintains: Buy
Price Target: $130 → $133
Current: $31.79
Upside: +318.37%
Apr 5, 2023
Maintains: Buy
Price Target: $24 → $16
Current: $2.65
Upside: +503.77%
Mar 2, 2023
Maintains: Buy
Price Target: $9 → $10
Current: $1.01
Upside: +890.10%
Sep 16, 2022
Maintains: Buy
Price Target: $45 → $44
Current: $3.41
Upside: +1,190.32%
Sep 16, 2022
Maintains: Buy
Price Target: $16 → $12
Current: $2.05
Upside: +485.39%
Sep 28, 2021
Upgrades: Buy
Price Target: n/a
Current: $5.03
Upside: -